KANTOFF AARON (CIK 1862734) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-31). Recent activity: Buy AVTX (3,166 shares), Sell TRML (88,281 shares), Sell TRML (5,000 shares), Buy TRML (37,890 shares), Buy TRML (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,166 | $0 |
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 88,281 | $0 |
| 2025-10-24 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 5,000 | $0 |
| 2025-09-09 | Tourmaline Bio, Inc. (TRML) | Director | Buy | 37,890 | $4,926 |
| 2025-09-09 | Tourmaline Bio, Inc. (TRML) | Director | Buy | 10,000 | $94,600 |
| 2025-04-01 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,167 | $0 |
Source: SEC Form 4 filings · as of 2026-03-31